Plasma levels of ADAMTS13 were within the normal range for the non‐stroke control cohort and SARS‐CoV2 negative IS cohort, while they were significantly decreased in the SARS‐CoV2 positive IS cohort. This evidence concerns the gene ADAMTS13 and stroke disorder.